↓ Skip to main content

Benefits and Harms of Antihypertensive Treatment in Low-Risk Patients With Mild Hypertension

Overview of attention for article published in JAMA Internal Medicine, December 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
106 Mendeley
citeulike
1 CiteULike
Title
Benefits and Harms of Antihypertensive Treatment in Low-Risk Patients With Mild Hypertension
Published in
JAMA Internal Medicine, December 2018
DOI 10.1001/jamainternmed.2018.4684
Pubmed ID
Authors

James P. Sheppard, Sarah Stevens, Richard Stevens, Una Martin, Jonathan Mant, F. D. Richard Hobbs, Richard J. McManus

Twitter Demographics

The data shown below were collected from the profiles of 807 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 106 100%

Demographic breakdown

Readers by professional status Count As %
Other 19 18%
Researcher 16 15%
Student > Ph. D. Student 13 12%
Student > Postgraduate 12 11%
Professor > Associate Professor 9 8%
Other 37 35%
Readers by discipline Count As %
Medicine and Dentistry 69 65%
Unspecified 22 21%
Pharmacology, Toxicology and Pharmaceutical Science 6 6%
Nursing and Health Professions 5 5%
Computer Science 1 <1%
Other 3 3%

Attention Score in Context

This research output has an Altmetric Attention Score of 629. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 October 2019.
All research outputs
#10,846
of 13,772,738 outputs
Outputs from JAMA Internal Medicine
#164
of 3,722 outputs
Outputs of similar age
#572
of 309,536 outputs
Outputs of similar age from JAMA Internal Medicine
#10
of 120 outputs
Altmetric has tracked 13,772,738 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,722 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 131.0. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 309,536 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 120 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.